Other
Obese Adolescents
0
Pipeline Programs↗
0
Active Trials↗
1
Companies Involved↗
Obese Adolescents is an early-stage landscape with 0 programs across 1 company. The most active players are Eisai.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
9
clinical trials
Completed6 · 67%
Suspended1 · 11%
Terminated1 · 11%
Withdrawn1 · 11%
Clinical Trials
Trial Activity
9 trials
Activity and Metformin Intervention in Obese Adolescents
Completed·LLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's·Phase 4·NCT00934570·60 enrolled
Vascular and Metabolic Effects of Vitamin D Supplementation Associated With Lifestyle Management in Obese Adolescents
Completed·—·Phase 4·NCT02400151·49 enrolled
Acetaminophen Dosing in Obese Adolescents
Suspended·—·Phase 3·NCT03192566·6 enrolled
Effect of Exercise or Metformin on Nocturnal Blood Pressure and Other Risk Factors for CVD Among Obese Adolescents
Terminated·—·N/A·NCT00889876·26 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)